Actelion gets second boost for Opsumit with EU approval

Eric Palmer

The Swiss drugmaker said in a statement that the EC approved the drug for use by itself or in concert with another PAH drug. intends to begin selling it in Europe in February with Germany first in line to get it.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS